ACYP1 and neoplasm: Our study revealed that ACYP1 plays an adverse role in LIHC patients, although its implication may vary depending on clinical characteristics such as sex, race, tumor stage, tumor grade, vascular invasion, alcohol consumption, and hepatitis status according to multifactor regression analysis.